From APhA’s Pharmacy Today newsletter, Dec. 5: A bill introduced by Sens. Chuck Grassley (R-IA) and Ron Wyden (D-OR) attempts to crack down on any efforts by drug companies to overcharge taxpayers for Medicaid rebates. The bill would give HHS new authority to reclassify a drug and recoup rebates when a manufacturer deliberately misclassifies a drug in order to pay lower rebates. The lawmakers specifically mentioned Mylan, which paid $465 million to settle a lawsuit with the Justice Department in 2016.
Print Page
Email to a Friend